earnings
MN
NASDAQ · MNKD
MannKind Corporation
Healthcare · Biotechnology
$3.90
Up+$0.29 (+7.44%)
Updated Nov 9, 2026, 11:28 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.78B
- P/E ratio
- 53.97
- Dividend yield
- 0.00%
- 52-week range
- $2.23 – $6.51
- Volume
- 4.99M
- Avg. volume
- 3.97M
Price performance · MNKD
MNKD price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
MNKD closed at $3.90 after 20 trading sessions, up 24.60% for the selected period.
- Last close
- $3.90
- Period change
- +24.60%
- Period low
- $3.02
- Period high
- $3.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $3.92 | $4.0949 | $3.80 | $3.90 | 4.99M |
| Nov 5, 2026 | $3.93 | $3.97 | $3.665 | $3.76 | 5.41M |
| Nov 4, 2026 | $3.86 | $4.045 | $3.80 | $3.93 | 4.06M |
| Nov 3, 2026 | $3.66 | $3.76 | $3.619 | $3.73 | 4.87M |
| Nov 2, 2026 | $3.50 | $3.66 | $3.46 | $3.65 | 3.18M |
| Oct 30, 2026 | $3.50 | $3.57 | $3.45 | $3.50 | 2.01M |
| Oct 29, 2026 | $3.49 | $3.57 | $3.48 | $3.50 | 2.28M |
| Oct 28, 2026 | $3.26 | $3.465 | $3.235 | $3.43 | 3.08M |
| Oct 27, 2026 | $3.23 | $3.30 | $3.17 | $3.29 | 2.51M |
| Oct 26, 2026 | $3.21 | $3.275 | $3.15 | $3.23 | 1.98M |
| Oct 23, 2026 | $3.18 | $3.205 | $3.09 | $3.19 | 3.09M |
| Oct 22, 2026 | $3.03 | $3.21 | $3.01 | $3.20 | 3.25M |
| Oct 21, 2026 | $3.10 | $3.13 | $3.04 | $3.05 | 2.8M |
| Oct 20, 2026 | $3.11 | $3.18 | $3.08 | $3.10 | 2.17M |
| Oct 19, 2026 | $3.18 | $3.22 | $3.07 | $3.09 | 2.46M |
| Oct 16, 2026 | $3.20 | $3.24 | $3.02 | $3.04 | 2.61M |
| Oct 15, 2026 | $3.02 | $3.20 | $2.995 | $3.19 | 3.76M |
| Oct 14, 2026 | $3.00 | $3.125 | $2.895 | $3.02 | 7.94M |
| Oct 13, 2026 | $3.13 | $3.14 | $3.02 | $3.05 | 4.39M |
| Oct 12, 2026 | $3.24 | $3.27 | $3.075 | $3.13 | 3.96M |
Latest MNKD news
The latest Smart Investors Daily articles mentioning MNKD.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

